CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Availability of technologically advanced bowel management products
4.1.2. The rise in the geriatric population
4.1.3. Expanding the target patient population
4.1.4. Favourable reimbursement scenario in developed economies
4.2. Market Restraints & Challenges
4.2.1. Discomfort associated with the use of bowel management devices
4.2.2. Patient preference for non-invasive clinical management
4.3. Market Opportunities
4.3.1. Disparities in reimbursement for bowel management products
CHAPTER 5. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET – BY
PRODUCT
5.1. Irrigation systems
5.2. Nerve Modulation Devices
5.3. Colostomy Bags
5.4. Others
CHAPTER 6. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET – BY
PATIENT TYPE
6.1. Pediatric Patients
6.2. Adult Patients
CHAPTER 7. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET – BY END
USER
7.1. Homecare
7.2. Hospitals & Ambulatory surgery centres
CHAPTER 8. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET - COMPANY
PROFILES
9.1. Aquaflush Medical Limited
9.2. Axonics Modulation Technologies
9.3. B. Braun Melsungen AG
9.4. C. R. Bard Inc. (Now Part of Becton Dickinson)
9.5. Cogentix Medical
9.6. Coloplast A/S
9.7. Consure Medical Private Ltd.
9.8. Convatec Group PLC
9.9. Hollister Incorporated
9.10. Mbh-International A/S
9.11. Mederi Therapeutics Inc.
9.12. Medtronic PLC
9.13. Welland Medical Limited (Part of Clinimed Group)
9.14. Wellspect Healthcare (Part of Dentsply Sirona Company)
CHAPTER 10. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
